{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:17:35Z","timestamp":1785842255339,"version":"3.56.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ygyno.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T15:46:26Z","timestamp":1402501586000},"page":"393-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"title":["Endometrial cancer: A review and current management strategies: Part II"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1288-4590","authenticated-orcid":false,"given":"William M.","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emery","family":"Salom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Olawaiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Boruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi Abu","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.06.003_bb0005","author":"Societies, C.o.M.S."},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","article-title":"Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study","volume":"108","author":"Susumu","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0090-8258(03)00087-8","article-title":"Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy","volume":"89","author":"Straughn","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"9213","key":"10.1016\/j.ygyno.2014.06.003_bb0025","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ygyno.2014.06.003_bb0030","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"9658","key":"10.1016\/j.ygyno.2014.06.003_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"issue":"9717","key":"10.1016\/j.ygyno.2014.06.003_bb0045","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ygyno.2014.06.003_bb0050","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0055","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2014a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"10.1016\/j.ygyno.2014.06.003_bb0060","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2010.04.005","article-title":"Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis","volume":"118","author":"Barlin","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(97)00581-6","article-title":"Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy","volume":"40","author":"Turner","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/gyno.1999.5444","article-title":"The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma","volume":"74","author":"Zanotti","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0360-3016(91)90744-O","article-title":"Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma","volume":"21","author":"Gibbons","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ygyno.2014.06.003_bb0090","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/bjc.1997.313","article-title":"Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy","volume":"75","author":"Onda","year":"1997","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ygyno.2008.11.026","article-title":"Sequential chemotherapy and irradiation in advanced stage endometrial cancer: a Gynecologic Oncology Group phase I trial of doxorubicin\u2013cisplatin followed by whole abdomen irradiation","volume":"112","author":"Fowler","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.ygyno.2014.06.003_bb0100","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2014results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/gyno.1999.5569","article-title":"FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy","volume":"75","author":"Nelson","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.06.035","article-title":"Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation","volume":"115","author":"Klopp","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0115","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ygyno.2005.03.011","article-title":"Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study","volume":"97","author":"Sutton","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.1016\/j.ygyno.2014.06.003_bb0120","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2004.02.088","article-title":"Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"22","author":"Thigpen","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mdg112","article-title":"Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group","volume":"14","author":"Aapro","year":"2003","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ygyno.2014.06.003_bb0130","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2004.07.184","article-title":"Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"22","author":"Fleming","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2006.03.019","article-title":"Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study","volume":"103","author":"Sovak","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1447-0756.2006.00405.x","article-title":"Paclitaxel\/carboplatin versus cyclophosphamide\/adriamycin\/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma","volume":"32","author":"Hidaka","year":"2006","journal-title":"J Obstet Gynaecol Res"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2014.06.003_bb0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-1438.2006.00413.x","article-title":"Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel","volume":"16","author":"Vaidya","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"9698","key":"10.1016\/j.ygyno.2014.06.003_bb0150","doi-asserted-by":"crossref","first-page":"1331,1338","DOI":"10.1016\/S0140-6736(09)61157-0","article-title":"Dose-dense paclitaxel once a week in combination with carboplatin every 3weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial","volume":"374","author":"Katsumata","year":"2009","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.ygyno.2014.06.003_bb0155","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/IGC.0b013e3181ad3dcb","article-title":"Leuven dose-dense paclitaxel\/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma","volume":"19","author":"Vandenput","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2004.02.008","article-title":"Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III\u2013IV endometrial cancer patients","volume":"93","author":"Bruzzone","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygyno.2008.10.009","article-title":"Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case\u2013control analysis","volume":"112","author":"Landrum","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0170","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2009.11.025","article-title":"A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the \u201csandwich\u201d method for high risk endometrial carcinoma","volume":"118","author":"Geller","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2010.12.338","article-title":"A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a \u201cSandwich\u201d method for stage III, IV, and recurrent endometrial cancer","volume":"121","author":"Geller","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2007.06.014","article-title":"The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer","volume":"107","author":"Alvarez Secord","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2003.09.018","article-title":"Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Whitney","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.06.003_bb0195","first-page":"437","article-title":"Synchronous endometrioid carcinoma of the uterine corpus and ovary. A case report and review of the literature","volume":"30","author":"Grammatoglou","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2014.06.003_bb0200","doi-asserted-by":"crossref","first-page":"465162","DOI":"10.1155\/2010\/465162","article-title":"The association between primary endometrioid carcinoma of the ovary and synchronous malignancy of the endometrium","volume":"2010","author":"van Niekerk","year":"2010","journal-title":"Obstet Gynecol Int"},{"issue":"36","key":"10.1016\/j.ygyno.2014.06.003_bb0205","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1200\/JCO.2005.03.5915","article-title":"Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?","volume":"23","author":"Soliman","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.06.003_bb0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/PAS.0000000000000177","article-title":"Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0215","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ygyno.2013.10.011","article-title":"Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist","volume":"131","author":"Daniels","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0029-7844(97)00668-6","article-title":"Profile of women 45years of age and younger with endometrial cancer","volume":"91","author":"Evans-Metcalf","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0225","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1006\/gyno.2001.6434","article-title":"Endometrial cancer in women 40years old or younger","volume":"83","author":"Duska","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0230","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2009.05.038","article-title":"Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?","volume":"114","author":"Navarria","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0240","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/AOG.0b013e3181ab6784","article-title":"Endometrial cancer risk among younger, overweight women","volume":"114","author":"Thomas","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.06.003_bb0245","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/AOG.0b013e31817051d9","article-title":"Lynch syndrome in women less than 50years of age with endometrial cancer","volume":"111","author":"Matthews","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.ygyno.2014.06.003_bb0250","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review","volume":"296","author":"Lindor","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ygyno.2014.06.003_bb0255","first-page":"612","article-title":"Accuracy of office and operating room curettage in the grading of endometrial carcinoma","volume":"71","author":"Daniel","year":"1988","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0029-7844(95)00105-Z","article-title":"Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer","volume":"86","author":"Larson","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.06.003_bb0265","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00004728-199509000-00013","article-title":"Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI","volume":"19","author":"Kim","year":"1995","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/GRF.0b013e318218607c","article-title":"Management of endometrial cancer in young women","volume":"54","author":"Shah","year":"2011","journal-title":"Clin Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ygyno.2014.06.003_bb0275","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/IGC.0b013e3181e94f5a","article-title":"Fertility-sparing therapy in young women with endometrial cancer: 2010 update","volume":"20","author":"Erkanli","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"19","key":"10.1016\/j.ygyno.2014.06.003_bb0280","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0285","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tjog.2009.10.006","article-title":"Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review","volume":"50","author":"Chao","year":"2011","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0290","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.06.041","article-title":"Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean Gynecologic Oncology Group","volume":"115","author":"Lee","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ygyno.2014.06.003_bb0295","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.2008.19.8150","article-title":"Safety of ovarian preservation in premenopausal women with endometrial cancer","volume":"27","author":"Wright","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.06.003_bb0300","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.AOG.0000172423.64995.6f","article-title":"Coexisting ovarian malignancy in young women with endometrial cancer","volume":"106","author":"Walsh","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"8 Suppl.","key":"10.1016\/j.ygyno.2014.06.003_bb0305","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0315","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1525-1438.2006.00534.x","article-title":"Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer","volume":"16","author":"Taskiran","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0320","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0090-8258(85)90235-5","article-title":"Role of whole abdominal radiation therapy in the management of endometrial cancer; prognostic importance of factors indicating peritoneal metastases","volume":"21","author":"Potish","year":"1985","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.06.003_bb0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0360-3016(87)90253-7","article-title":"Primary radiation therapy for medically inoperable patients with endometrial carcinoma\u2014stages I\u2013II","volume":"13","author":"Varia","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ygyno.2014.06.003_bb0330","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.brachy.2008.11.006","article-title":"The management of inoperable Stage I endometrial cancer using intracavitary brachytherapy alone: a 20-year institutional review","volume":"8","author":"Shenfield","year":"2009","journal-title":"Brachytherapy"},{"issue":"6","key":"10.1016\/j.ygyno.2014.06.003_bb0335","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.06.003_bb0340","doi-asserted-by":"crossref","first-page":"498","DOI":"10.6004\/jnccn.2009.0035","article-title":"Uterine neoplasms. Clinical practice guidelines in oncology","volume":"7","author":"Greer","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.ygyno.2014.06.003_bb0345","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/ijc.25762","article-title":"Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study","volume":"128","author":"Jaakkola","year":"2011","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.06.003_bb0350","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.ygyno.2014.06.003_bb0355","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/aje\/kwq300","article-title":"Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition","volume":"172","author":"Allen","year":"2010","journal-title":"Am J Epidemiol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814010282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814010282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T08:53:28Z","timestamp":1565513608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814010282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0090825814010282"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.06.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrial cancer: A review and current management strategies: Part II","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}